Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
Charles River Laboratories (CRL) will release its first-quarter 2022 financial results on May 4, before market opening. A conference call to discuss these results is scheduled for the same day at 9:30 a.m. ET. Investors can access the live webcast through the Investor Relations section on CRL's website. The company offers key products and services aimed at accelerating research and drug development for pharmaceutical and biotech sectors.
- Scheduled release of Q1 2022 financial results may indicate stable financial health.
- Opportunity for investor engagement through conference call.
- None.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220413005915/en/
Investor Relations:
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source:
FAQ
When will Charles River Laboratories release its Q1 2022 earnings?
What time is the conference call for CRL's Q1 2022 earnings?